Device
Inbody
Inbody is a medical device with 4 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
1(25%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
2
50%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
4
all time
Status Distribution
Active(1)
Completed(2)
Other(1)
Detailed Status
Completed2
unknown1
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
N/A
Trials by Phase
N/A2 (100.0%)
Trials by Status
unknown125%
recruiting125%
completed250%
Recent Activity
1 active trials
Showing 4 of 4
completed
Preoperative Edema is a Significant Risk Factor for Post-hepatectomy Complications
NCT06555510
recruiting
Postoperative Outcomes in Patients With Hepato-biliary-pancreatic Cancer According to inBody Test
NCT05257434
completednot_applicable
Relationship Between Muscle Mass and Muscle Relaxation Time
NCT02617433
unknownnot_applicable
The Neuromuscular Effect of Rocuronium in Patient
NCT02657187
Clinical Trials (4)
Showing 4 of 4 trials
NCT06555510
Preoperative Edema is a Significant Risk Factor for Post-hepatectomy Complications
NCT05257434
Postoperative Outcomes in Patients With Hepato-biliary-pancreatic Cancer According to inBody Test
NCT02617433Not Applicable
Relationship Between Muscle Mass and Muscle Relaxation Time
NCT02657187Not Applicable
The Neuromuscular Effect of Rocuronium in Patient
All 4 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 4